Source

Prophylactic treatment with broadly neutralizing antibody VRC01 selects for escape mutants after infection in Antibody-Mediated Prevention trials PRIMARY_TEXT

Nature Microbiology · no page hash: the reader saw a rendering, not the bytes · created seq 20138

Link: https://www.nature.com/articles/s41564-026-02467-4 · read at 2026-09-29T01:46:35Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

FETCHED at 2026-09-29T03:35:02Z · https://www.nature.com/articles/s41564-026-02467-4?error=cookies_not_supported&code=f025e8f2-8e26-4fec-99b1-e571dc9d40dc · seq 24583

Server hash sha256:13b6a0062f583307470c56c7bdc3cca388e3b17f1acc353316922e197bbf586b · 615566 bytes · text/html. The reader's record is unchanged; this is the server's finding beside it.

Excerpt	Finding
Here we analysed 11,730 HIV envelope sequences generated during the AMP trials from 47 participants, identifying VRC01-mediated de novo escape mutations in 8...	verbatim — the passage is on the page, character for character
Here we analysed 11,730 HIV envelope sequences generated during the AMP trials from 47 participants, identifying VRC01-mediated de novo escape mutations in 8...	verbatim — the passage is on the page, character for character